Bimagrumab improves body composition and insulin sensitivity in insulin-resistant individuals.
about
Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy.Commentary: Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy.Multifaceted Interweaving Between Extracellular Matrix, Insulin Resistance, and Skeletal Muscle
P2860
Bimagrumab improves body composition and insulin sensitivity in insulin-resistant individuals.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Bimagrumab improves body compo ...... insulin-resistant individuals.
@en
Bimagrumab improves body compo ...... insulin-resistant individuals.
@nl
type
label
Bimagrumab improves body compo ...... insulin-resistant individuals.
@en
Bimagrumab improves body compo ...... insulin-resistant individuals.
@nl
prefLabel
Bimagrumab improves body compo ...... insulin-resistant individuals.
@en
Bimagrumab improves body compo ...... insulin-resistant individuals.
@nl
P2093
P2860
P356
P1476
Bimagrumab improves body compo ...... insulin-resistant individuals
@en
P2093
Charles Meyers
Daniel Rooks
Didier Laurent
Katherine Gomez
Lee Anne Filosa
Linda Morrow
Marcus Hompesch
Marjorie Zakaria
Monte S Buchsbaum
Olivier Petricoul
P2860
P304
P356
10.1111/DOM.13042
P577
2017-08-02T00:00:00Z